Concepedia

Omar Nadeem

ON

Statistics

Publications

40

Citations

1.8K

H-Index

22

Active since

2012

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Massachusetts General Hospital

Levine Cancer Institute

University of Maryland, Baltimore

Omar Nadeem is an author at Dana-Farber Cancer Institute specializing in multiple myeloma, multiple myeloma therapy, and oncology.

ORCID

Publications per year

2012–2025

40

Publications

40

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

Paul G. Richardson, Susanna Jacobus, Edie Weller et al. · New England Journal of Medicine · 2022 · 463 citations · Full text

, , +14

Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma

Paul G. Richardson, Albert Oriol, Alessandra Larocca et al. · Journal of Clinical Oncology · 2020 · 155 citations · Full text

, , +14

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Surbhi Sidana, Krina K. Patel, Lauren C. Peres et al. · Blood · 2024 · 124 citations · Full text

, , +14

Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy

Christopher J. Ferreri, Michelle A.T. Hildebrandt, Hamza Hashmi et al. · Blood Cancer Journal · 2023 · 111 citations · Full text

, , +17

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

Annie Cowan, Federico Ferrari, Samuel S. Freeman et al. · The Lancet Haematology · 2023 · 80 citations · Full text

, , +17

1–5 of 40